AUS
NZ
UK
CA
USA
FRA
GER
ESP
ITA
NLD
PRT
SWE
GRC
IND
POL
BRA
ZAF
RUS
CHN
UAE
Healthcare
Kalkine: Leadership Change at Integral Diagnostics (ASX:IDX) as CEO Sets Retirement Timeline | ASX200 Update
June 06, 2025 05:07 PM AEST| By Team Kalkine MediaHighlights,Integral Diagnostics (IDX) CEO to retire by FY26-end,Leadership transition aligned with recent Capitol Health merger,New CEO search underway amid ASX200 index presence,Integral Diagnostics (ASX:IDX), a key player in the medical imaging spa...
Kalkine: Imugene Advances Cancer Pipeline with New Trial Milestones and CMO Leadership
June 06, 2025 01:43 PM AEST| By Team Kalkine MediaHighlights,Imugene Ltd (ASX:IMU, OTC:IUGNF) initiates Phase 2 trials for PD1-Vaxx in Australia,New CMO Dr John Byon focuses on durable responses in advanced therapies,Expansion into rare blood cancers and strategic development for onCARlytics continu...
Kalkine: Imugene’s Oncology Pipeline Progresses with Key Trials and ASX200 Outlook (ASX:IMU)
June 06, 2025 01:31 PM AEST| By Team Kalkine MediaHighlights,Dr John Byon appointed as chief medical office,Azer-cel shows durable responses post CAR-T failure,First site activated in PD1-Vaxx Phase 2 colorectal cancer trial,Imugene Ltd (ASX:IMU) continues to make strides in oncology innovation, rec...
Kalkine: EBR Systems Shares Surge on First US Implants, Gains Spotlight in ASX200 Landscape
June 06, 2025 11:32 AM AEST| By Team Kalkine MediaHighlights,EBR Systems performs first US commercial implants,Shares spike over 7% on the news,Positioned for upcoming limited market release,EBR Systems (ASX:EBR) made headlines after announcing a key milestone — the first commercial implantations of...
Kalkine: ASX 200 Faces Legal Uncertainty as Mayne Pharma Proceeds with Cosette Deal Vote
June 05, 2025 03:57 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma Group Ltd (ASX:MYX) to continue with shareholder vote on Cosette Pharma's acquisition,Cosette declares deal termination citing material change; Mayne challenges the claim,Supreme Court defers approval hearing pending outcome o...
Kalkine : ASX 200 Pharma Stock CU6 Surges on Positive Phase II Trial Update
June 05, 2025 03:52 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals shares rise sharply after a key clinical trial update,64Cu-SARTATE shows enhanced detection of NET lesions over current standard,Plans underway to progress into a registrational study with FDA guidance,Clarity Pharm...
Kalkine: ASX 200 Lifts as Clarity Pharma Reports Diagnostic Trial Milestone
June 05, 2025 03:43 PM AEST| By Team Kalkine MediaHighlights,Clarity Pharmaceuticals (ASX:CU6) announces positive phase two results for Cu-SARTATE in NET patients,Company plans to advance discussions with the US FDA for phase three diagnostic study,ASX 200 strengthens on healthcare gains and upbeat...
Kalkine: ASX 200 Healthcare Tech Sector Sees Lift as Ramsay CEO Joins EMVision Board
June 05, 2025 03:17 PM AEST| By Team Kalkine MediaHighlights,EMVision Medical Devices (ASX:EMV) welcomes Ramsay Health Care CEO Carmel Monaghan to its board,Monaghan brings decades of healthcare leadership experience to EMV as a non-executive director,Market movement observed following board appoint...
Kalkine: ASX 200 Healthcare: What’s Driving Movement in Cochlear Ltd (ASX:COH) Shares?
June 05, 2025 03:03 PM AEST| By Team Kalkine MediaHighlights,Cochlear Ltd (ASX:COH) shares have shown a decline since the start of the year amid broader healthcare sector trends,The healthcare sector continues to be influenced by essential service demand and consistent revenue models,Valuation metri...
Kalkine:ASX 200-Medical Device Makers Lead Healthcare Sector
June 05, 2025 01:52 PM AEST| By Team Kalkine MediaHighlights,ASX-listed medical device manufacturers show resilience in contrast to declining biotech valuations in the US,Nasdaq Biotechnology Index has declined, while US medtech ETFs recorded gains over the past year,ASX companies such as ResMed (AS...
Kalkine : ASX 200 Mining and Healthcare Leaders-Mineral Resources and ResMed Overview
June 05, 2025 01:02 PM AEST| By Team Kalkine MediaHighlights,Mineral Resources Limited (ASX:MIN) operates in lithium and iron ore mining, supported by integrated engineering services across multiple Australian states.,ResMed CDI (ASX:RMD) focuses on cloud-connected medical equipment for sleep apnea...
Kalkine: Mayne Pharma Sees Share Boost Amid Cosette Takeover Uncertainty
June 04, 2025 02:54 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma's share price climbs as Cosette Pharmaceuticals has not formally withdrawn its takeover proposal,FDA issues letter indicating prior concerns around Nextstellis have been resolved,Mayne Pharma reiterates its position on materia...
Kalkine: Mayne Pharma (ASX:MYX) Lifts as Cosette Keeps Takeover Door Open
June 04, 2025 02:39 PM AEST| By Team Kalkine MediaHighlights,Mayne Pharma shares advanced as Cosette Pharmaceuticals has not yet withdrawn its takeover offer,The company addressed FDA concerns that were previously flagged as material by Cosette,Takeover developments come amid broader activity on the...
Kalkine: ASX200 Shock: Cosette Walks Away from $672M Mayne Pharma Deal Amid Earnings & Regulatory Woes
June 04, 2025 02:21 PM AEST| By Team Kalkine MediaHighlights,Cosette seeks to end $672 million Mayne Pharma deal,Mayne Pharma rejects claims of financial deterioration,Regulatory and earnings concerns spark investor reaction,In a significant shake-up for the,ASX200,, U.S.-based pharmaceutical firm C...
Kalkine: Why Sonic Healthcare (ASX:SHL) Could Be a Key Contender in the ASX200 Healthcare Space
June 04, 2025 01:51 PM AEST| By Team Kalkine MediaHighlights,SHL shares trading below 5-year average valuation,Healthcare sector offers stable long-term potential,Ethical and defensive traits boost sector appeal,Sonic Healthcare Ltd (ASX:SHL) has long stood as a significant player in the global heal...
Kalkine: Chimeric Therapeutics’ Breakthrough Cancer Therapy Gains FDA Fast-Track: A Promising Leap for ASX200 Biotech Space
June 04, 2025 11:58 AM AEST| By Team Kalkine MediaHighlights,Chimeric Therapeutics receives FDA fast-track status for cancer drug,Novel CAR-T therapy targets unmet need in gastrointestinal,tumours,Ongoing clinical trial builds momentum for potential treatment,Chimeric Therapeutics (ASX:CHM) has take...
Kalkine: Mayne Pharma's $672 Million Deal with Cosette Faces Uncertainty Amid ASX200 Volatility
June 04, 2025 11:14 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma warns Cosette may still,terminate,acquisition offer,FDA concerns and financial performance cited as key issues,ASX dividend stocks,remain,in focus amid pharma sector m,The proposed $672 million acquisition of Mayne Pharma Grou...
Kalkine: Mayne Pharma Faces ASX200 Uncertainty as Cosette Remains Silent on $672M Takeover
June 04, 2025 10:52 AM AEST| By Team Kalkine MediaHighlights,Mayne Pharma awaits clarity from Cosette on proposed deal,FDA concerns addressed, says Mayne,Share price trades well below offer value,Mayne Pharma (ASX:MYX) finds itself in a critical phase as it awaits a formal response from US-based Cos...
Kalkine: Is Nanosonics (ASX:NAN) Staying Resilient Despite Weak Price Trends?
June 03, 2025 02:33 PM AEST| By Team Kalkine MediaHighlights,Nanosonics operates within the healthcare sector and is listed on the ASX 200,The company’s return on equity aligns with broader industry benchmarks,Profits are being retained and reinvested, supporting earnings growth,Nanosonics Limited (...
Kalkine: ASX 200 Biotech Stocks Show Signs of Resilience Despite Choppy May
June 03, 2025 02:25 PM AEST| By Team Kalkine MediaHighlights,MedAdvisor and Dimerix record strong market cap increases,Emvision and Paradigm advance pivotal clinical trials,Select companies complete capital raisings amid funding challenges,The Australian biotechnology sector, part of the broader,ASX...
Advertise your brand on Kalkine Media